SCHEMBL28416630

SCHEMBL28416630

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(C(=O)N4CCNCC4)ccc3OCC)nc12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 18/20 0.76
PDE6C P51160 3/20 0.76
HDAC1 Q13547 10/20 0.66
HDAC6 Q9UBN7 10/20 0.66
HDAC2 Q92769 6/20 0.66
HDAC3 O15379 1/20 0.65
NCOR2 Q9Y618 1/20 0.65
PDE3B Q13370 2/20 0.63
PDE3A Q14432 2/20 0.63
KMT2A Q03164 2/20 0.63
PDE1A P54750 2/20 0.63
PDE1B Q01064 2/20 0.63
PDE1C Q14123 2/20 0.63
MEN1 O00255 1/20 0.63
ALDH1A1 P00352 1/20 0.63
HPGD P15428 1/20 0.63
PDE2A O00408 1/20 0.62
ABCC4 O15439 1/20 0.62
ABCC5 O15440 1/20 0.62
PDE6D O43924 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29707546 0.93 PDE5A (0.77) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL145682 0.93 PDE5A (0.77) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL31174347 0.91 PDE5A (0.75) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL25013643 0.91 PDE5A (0.75) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL28476705 0.90 PDE5A (0.72) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL7965731 0.89 PDE5A (0.84) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL7961020 0.86 PDE5A (1.00) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL7960838 0.86 PDE5A (0.86) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL26766367 0.86 PDE5A (0.85) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL18714952 0.86 PDE5A (0.85) PDE5APDE6CHDAC1HDAC6HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN claimed
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN disclosed